wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33396522-2E4218F6-84B0-4558-93E5-1B21D9CFEA0A
Q33396522-2E4218F6-84B0-4558-93E5-1B21D9CFEA0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33396522-2E4218F6-84B0-4558-93E5-1B21D9CFEA0A
A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma.
P2860
Q33396522-2E4218F6-84B0-4558-93E5-1B21D9CFEA0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33396522-2E4218F6-84B0-4558-93E5-1B21D9CFEA0A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f6bf1959d2c140cbf5b658c8099a93a557958da
P2860
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma.